Advertisement
Organisation › Details
Stern Investor Relations Inc. (Stern IR)
Start | 1998-01-01 established (approx) | |
Group | Precision Medicine Group (Group) | |
Industry | public relations / investor relations / marcom (services) | |
Industry 2 | LIFE SCIENCES | |
Person | DelGiacco, Beth (Argenx 201806– VP Investor Relations before Stern IR) | |
Region | New York, NY | |
Country | United States (USA) | |
City | n. a. New York, NY | |
Tel | +1-212-362-1200 | |
Address record changed: 2024-01-05 | ||
Basic data | Employees | n. a. |
Record changed: 2024-01-03 |
Advertisement
More documents for Precision Medicine Group (Group)
- [1] Quell Therapeutics Ltd.. (1/6/22). "Press Release: Quell Therapeutics Announces Presentation at the 40th Annual J.P. Morgan Healthcare Conference". London & Boston, MA....
- [2] iTeos Therapeutics S.A.. (2/27/20). "Press Release: iTeos Therapeutics Initiates Phase 1/2 Study with Highly Innovative Anti-TIGIT Antibody in Patients with Advanced Cancers". Cambridge, MA & Gosselies....
- [3] Argen-X N.V. (Argenx). (11/13/17). "Press Release: Argenx to Present at Upcoming Investor Conferences". Breda & Ghent....
- [4] Precision for Medicine. (10/4/17). "Press Release: Precision for Medicine Acquires Epiontis – a Leading Immune Monitoring and Epigenetic Technology Service Provider". Bethesda, MD & Berlin....
- [5] Pharnext S.A.. (9/5/17). "Press Release: Pharnext to Present at Rodman & Renshaw 19th Annual Global Investment Conference". Paris....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top